Biopower Operatn Financials

Biopower Operatn (BOPO) reported $572K in total revenue for fiscal year 2022. This represents a 226.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Biopower Operatn (BOPO) revenue grew by 226.7% year-over-year, from $175K to $572K in fiscal year 2022.

No, Biopower Operatn (BOPO) reported a net income of -$793K in fiscal year 2022, with a net profit margin of -138.6%.

Biopower Operatn (BOPO) had an operating margin of -103.5% in fiscal year 2022, reflecting the profitability of core business operations before interest and taxes.

Biopower Operatn (BOPO) had a net profit margin of -138.6% in fiscal year 2022, representing the share of revenue converted into profit after all expenses.

Biopower Operatn (BOPO) generated $306K in operating cash flow during fiscal year 2022, representing cash generated from core business activities.

Biopower Operatn (BOPO) had $14K in total assets as of fiscal year 2022, including both current and long-term assets.

Biopower Operatn (BOPO) had 46M shares outstanding as of fiscal year 2022.

Biopower Operatn (BOPO) had a debt-to-equity ratio of -1.00 as of fiscal year 2022, measuring the company's financial leverage by comparing total debt to shareholder equity.

Biopower Operatn (BOPO) had a return on assets of -5641.2% for fiscal year 2022, measuring how efficiently the company uses its assets to generate profit.

Biopower Operatn (BOPO) has negative shareholder equity of -$5.9M as of fiscal year 2022, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Biopower Operatn (BOPO) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Biopower Operatn (BOPO) has an earnings quality ratio of -0.39x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.